AAFA's Advocacy for Health Equity Leads to White House Address on Asthma Inhaler Pricing
April 03, 2024 14:45 ET
|
Asthma and Allergy Foundation of America
Washington, DC, April 03, 2024 (GLOBE NEWSWIRE) -- As the leading advocacy organization focused on improving the access and affordability of asthma inhalers, the Asthma and Allergy Foundation of...
AAFA Statement on Asthma Inhaler Price Caps
March 08, 2024 08:53 ET
|
Asthma and Allergy Foundation of America
Washington, DC, March 08, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is leading advocacy efforts to change the drug pricing ecosystem and to make medicines more...
Health Insurer Calls for Rx Transparency
September 23, 2015 16:03 ET
|
Capital District Physicians' Health Plan, Inc.
ALBANY, N.Y., Sept. 23, 2015 (GLOBE NEWSWIRE) -- An Albany, NY-based health insurer has asked the pharmaceutical industry to "show me the money." CDPHP today called for price transparency and cost...
Pharmacy Benefit Management Institute Expands Content of 16th Annual Drug Benefit Design Survey
March 18, 2010 14:27 ET
|
Pharmacy Benefit Management Institute
SCOTTSDALE, AZ--(Marketwire - March 18, 2010) - The Pharmacy Benefit Management Institute (PBMI) is expanding the scope of its benefits research on prescription drug costs and plan design to...
Employers Effectively Controlling Drug Benefit Costs
October 07, 2009 12:29 ET
|
Pharmacy Benefit Management Institute, LP (PBMI)
SCOTTSDALE, AZ--(Marketwire - October 7, 2009) - Employers are effectively controlling drug
benefit costs and utilization, according to research findings in the Pharmacy Benefit Management...
Pharmacy Benefit Management Institute Expands Content of 15th Annual Drug Benefit Design Survey
May 05, 2009 09:30 ET
|
Pharmacy Benefit Management Institute (PBMI)
SCOTTSDALE, AZ--(Marketwire - May 5, 2009) - The Pharmacy
Benefit Management Institute (PBMI) is expanding the scope of its
legacy study on prescription costs and
drug benefit plan design to...